<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32286313</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>14</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>1773</StartPage><MedlinePgn>1773</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1773</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-15644-8</ELocationID><Abstract><AbstractText>In amyotrophic lateral sclerosis (ALS), immune cells and glia contribute to motor neuron (MN) degeneration. We report the presence of NK cells in post-mortem ALS motor cortex and spinal cord tissues, and the expression of NKG2D ligands on MNs. Using a mouse model of familial-ALS, hSOD1<sup>G93A</sup>, we demonstrate NK cell accumulation in the motor cortex and spinal cord, with an early CCL2-dependent peak. NK cell depletion reduces the pace of MN degeneration, delays motor impairment and increases survival. This is confirmed in another ALS mouse model, TDP43<sup>A315T</sup>. NK cells are neurotoxic to hSOD1<sup>G93A</sup> MNs which express NKG2D ligands, while IFN&#x3b3; produced by NK cells instructs microglia toward an inflammatory phenotype, and impairs FOXP3<sup>+</sup>/Treg cell infiltration in the spinal cord of hSOD1<sup>G93A</sup> mice. Together, these data suggest a role of NK cells in determining the onset and progression of MN degeneration in ALS, and in modulating Treg recruitment and microglia phenotype.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy. stefano.garofalo@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cocozza</LastName><ForeName>Germana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Neuromed, Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porzia</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inghilleri</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5365-3417</Identifier><AffiliationInfo><Affiliation>Department of Human Neuroscience, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raspa</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>EMMA CNR, Monterotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scavizzi</LastName><ForeName>Ferdinando</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4483-6753</Identifier><AffiliationInfo><Affiliation>EMMA CNR, Monterotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronica</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, department of (Neuro)Pathology, Amsterdam Neuroscience, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardini</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3705-2598</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, laboratory affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Ling</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3990-5248</Identifier><AffiliationInfo><Affiliation>Aix-Marseille Universit&#xe9;, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille, UMR 7325, &#xab;Equipe Labellis&#xe9;e Ligue Contre le Cancer&#xbb;, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ransohoff</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Third Rock Ventures, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoni</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Neuromed, Pozzilli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine, laboratory affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limatola</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7504-8197</Identifier><AffiliationInfo><Affiliation>IRCCS Neuromed, Pozzilli, Italy. cristina.limatola@uniroma1.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sapienza University, Laboratory affiliated to Istituto Pasteur Italia, Rome, Italy. cristina.limatola@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C112260">NCR1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055627">Natural Cytotoxicity Triggering Receptor 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055627" MajorTopicYN="N">Natural Cytotoxicity Triggering Receptor 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32286313</ArticleId><ArticleId IdType="pmc">PMC7156729</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-15644-8</ArticleId><ArticleId IdType="pii">10.1038/s41467-020-15644-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031&#x2013;2041. doi: 10.1016/S0140-6736(07)60944-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60944-1</ArticleId><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:459&#x2013;470. doi: 10.1002/mus.10191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10191</ArticleId><ArticleId IdType="pubmed">12362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav. Immun. 2011;25:1025&#x2013;1035. doi: 10.1016/j.bbi.2010.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.12.008</ArticleId><ArticleId IdType="pmc">PMC3096756</ArticleId><ArticleId IdType="pubmed">21176785</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA. 2006;103:16021&#x2013;16026. doi: 10.1073/pnas.0607423103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp. Neurol. 2012;237:147&#x2013;152. doi: 10.1016/j.expneurol.2012.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.06.011</ArticleId><ArticleId IdType="pmc">PMC4126417</ArticleId><ArticleId IdType="pubmed">22735487</ArticleId></ArticleIdList></Reference><Reference><Citation>Salter MW. Microglia emerge as central players in brain disease. Nat. Med. 2017;23:1018&#x2013;1027. doi: 10.1038/nm.4397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4397</ArticleId><ArticleId IdType="pubmed">28886007</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A. Disease-Associated Microglia: a Universal Immune Sensor of Neurodegeneration. Cell. 2018;173:1073&#x2013;1081. doi: 10.1016/j.cell.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.05.003</ArticleId><ArticleId IdType="pubmed">29775591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol. Dis. 2012;48:418&#x2013;428. doi: 10.1016/j.nbd.2012.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.07.008</ArticleId><ArticleId IdType="pmc">PMC3897268</ArticleId><ArticleId IdType="pubmed">22820142</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR. ALS patients&#x2019; regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2:e89530. doi: 10.1172/jci.insight.89530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.89530</ArticleId><ArticleId IdType="pmc">PMC5333967</ArticleId><ArticleId IdType="pubmed">28289705</ArticleId></ArticleIdList></Reference><Reference><Citation>Infante-Duarte C. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J. 2005;19:1902&#x2013;1904. doi: 10.1096/fj.05-3832fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-3832fje</ArticleId><ArticleId IdType="pubmed">16144955</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 2006;20:896&#x2013;905. doi: 10.1096/fj.05-5465com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5465com</ArticleId><ArticleId IdType="pubmed">16675847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertwig L. CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation. Eur. J. Immunol. 2016;46:1984&#x2013;1996. doi: 10.1002/eji.201546194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201546194</ArticleId><ArticleId IdType="pmc">PMC5020316</ArticleId><ArticleId IdType="pubmed">27325505</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli A. NK cells in central nervous system. J. Immunol. 2013;190:5355&#x2013;5362. doi: 10.4049/jimmunol.1203401.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1203401</ArticleId><ArticleId IdType="pubmed">23687193</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli A. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival. Oncotarget. 2013;4:1527&#x2013;1546. doi: 10.18632/oncotarget.1291.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.1291</ArticleId><ArticleId IdType="pmc">PMC3824525</ArticleId><ArticleId IdType="pubmed">24127551</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo S. Environmental stimuli shape microglial plasticity in glioma. elife. 2017;6:e33415. doi: 10.7554/eLife.33415.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.33415</ArticleId><ArticleId IdType="pmc">PMC5774898</ArticleId><ArticleId IdType="pubmed">29286001</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies AJ. Natural killer cells degenerate intact sensory afferents following nerve injury. Cell. 2019;176:716&#x2013;728. doi: 10.1016/j.cell.2018.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.12.022</ArticleId><ArticleId IdType="pmc">PMC6418410</ArticleId><ArticleId IdType="pubmed">30712871</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74:1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelstein A. Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. PLoS ONE. 2011;6:e22374. doi: 10.1371/journal.pone.0022374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022374</ArticleId><ArticleId IdType="pmc">PMC3149057</ArticleId><ArticleId IdType="pubmed">21829620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon MS. Inflammation, immunity and amyotrophic lateral sclerosis: Etiology and Pathology. Muscle Nerve. 2019;59:10&#x2013;12. doi: 10.1002/mus.26289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26289</ArticleId><ArticleId IdType="pubmed">29979464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc. Natl Acad. Sci. USA. 2009;106:20960&#x2013;20965. doi: 10.1073/pnas.0911405106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911405106</ArticleId><ArticleId IdType="pmc">PMC2791631</ArticleId><ArticleId IdType="pubmed">19933335</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I. TDP-43 mutant mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo S. Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice. Nat. Comm. 2015;30:6623. doi: 10.1038/ncomms7623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7623</ArticleId><ArticleId IdType="pmc">PMC4389244</ArticleId><ArticleId IdType="pubmed">25818172</ArticleId></ArticleIdList></Reference><Reference><Citation>Komine O. Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes. Cell Death Differ. 2018;25:2130&#x2013;2146. doi: 10.1038/s41418-018-0098-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0098-3</ArticleId><ArticleId IdType="pmc">PMC6261996</ArticleId><ArticleId IdType="pubmed">29568058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanier LL. NK cell recognition. Ann. Rev. Immunol. 2005;23:225&#x2013;274. doi: 10.1146/annurev.immunol.23.021704.115526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.23.021704.115526</ArticleId><ArticleId IdType="pubmed">15771571</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Liberto G. Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping. Cell. 2018;175:458&#x2013;471. doi: 10.1016/j.cell.2018.07.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.049</ArticleId><ArticleId IdType="pubmed">30173917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JH. IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis. Eur. J. Immunol. 2009;39:1241&#x2013;1251. doi: 10.1002/eji.200838913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200838913</ArticleId><ArticleId IdType="pubmed">19337996</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl Acad. Sci. USA. 2008;105:15558&#x2013;15563. doi: 10.1073/pnas.0807419105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807419105</ArticleId><ArticleId IdType="pmc">PMC2547419</ArticleId><ArticleId IdType="pubmed">18809917</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell Neurosci. 2006;31:427&#x2013;437. doi: 10.1016/j.mcn.2005.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.10.016</ArticleId><ArticleId IdType="pubmed">16337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Fl&#xfc;gel A. Neuronal MCP-1 expression in response to remote nerve injury. J. Cereb. Blood Flow. Metab. 2001;21:69&#x2013;76. doi: 10.1097/00004647-200101000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004647-200101000-00009</ArticleId><ArticleId IdType="pubmed">11149670</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J. Neurochem. 2008;104:254&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2186066</ArticleId><ArticleId IdType="pubmed">17944871</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe CL. Neuronal CCL2 expression drives inflammatory monocyte infiltration into the brain during acute virus infection. J. Neuroinfl. 2017;14:238. doi: 10.1186/s12974-017-1015-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-1015-2</ArticleId><ArticleId IdType="pmc">PMC5715496</ArticleId><ArticleId IdType="pubmed">29202854</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr. Opin. Neurol. 2018;31:635&#x2013;639. doi: 10.1097/WCO.0000000000000599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito AG. Motor neuron-immune interactions: the vicious circle of ALS. J. Neural Transm. 2010;117:981&#x2013;1000. doi: 10.1007/s00702-010-0429-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-010-0429-0</ArticleId><ArticleId IdType="pmc">PMC3511247</ArticleId><ArticleId IdType="pubmed">20552235</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G. Immune response in peripheral axons delays disease progression in SOD1G93A mice. J. Neuroinfl. 2016;13:261. doi: 10.1186/s12974-016-0732-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0732-2</ArticleId><ArticleId IdType="pmc">PMC5055725</ArticleId><ArticleId IdType="pubmed">27717377</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol. Med. 2013;5:64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawitzki B. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 2005;201:1925&#x2013;1935. doi: 10.1084/jem.20050419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050419</ArticleId><ArticleId IdType="pmc">PMC2212028</ArticleId><ArticleId IdType="pubmed">15967822</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill JA. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity. 2008;29:758&#x2013;770. doi: 10.1016/j.immuni.2008.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.09.018</ArticleId><ArticleId IdType="pmc">PMC3140207</ArticleId><ArticleId IdType="pubmed">19006694</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala M. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinfl. 2010;7:76&#x2013;90. doi: 10.1186/1742-2094-7-76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-76</ArticleId><ArticleId IdType="pmc">PMC2992053</ArticleId><ArticleId IdType="pubmed">21062492</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam L. Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients. FASEB J. 2016;30:3461&#x2013;3473. doi: 10.1096/fj.201600259RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600259RR</ArticleId><ArticleId IdType="pmc">PMC5024692</ArticleId><ArticleId IdType="pubmed">27368295</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiaoxuan L. Adaptive amphiphilic dendrimer based nanoassemblies as robust and versatile siRNA delivery systems. Angew. Chem. Int. Ed. 2014;53:11822&#x2013;11827. doi: 10.1002/anie.201406764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201406764</ArticleId><ArticleId IdType="pmc">PMC4485617</ArticleId><ArticleId IdType="pubmed">25219970</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A. Amyotrophic lateral sclerosis &amp; frontotemporal degeneration. A Revis. El Escorial criteria. 2015;16:291&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Guez-Barber D. FACS purification of immunolabeled cell types from adult rat brain. J. Neurosci. Methods. 2012;203:10&#x2013;18. doi: 10.1016/j.jneumeth.2011.08.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2011.08.045</ArticleId><ArticleId IdType="pmc">PMC3221768</ArticleId><ArticleId IdType="pubmed">21911005</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo S. The glycoside oleandrin reduces glioma growth with direct and indirect effects on tumor cells. J. Neurosci. 2017;37:3926&#x2013;3939. doi: 10.1523/JNEUROSCI.2296-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2296-16.2017</ArticleId><ArticleId IdType="pmc">PMC6596714</ArticleId><ArticleId IdType="pubmed">28292827</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocozza G. Ca2+-activated K+ channels modulate microglia affecting motor neuron survival in hSOD1G93A mice. Brain Behav. Immun. 2018;73:584&#x2013;595. doi: 10.1016/j.bbi.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6129409</ArticleId><ArticleId IdType="pubmed">29981425</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittgen TD. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008;3:1101&#x2013;1108. doi: 10.1038/nprot.2008.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.73</ArticleId><ArticleId IdType="pubmed">18546601</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C. Development of a method for measuring cell number: application to CNS primary neuronal cultures. Cytometry. 1994;17:274&#x2013;276. doi: 10.1002/cyto.990170311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.990170311</ArticleId><ArticleId IdType="pubmed">7851163</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>